Cannabis Regulations, SOR/2018-144
Section 228
Antimicrobial treatment
Cite as Cannabis Regulations, SOR/2018-144, s. 228 · current to June 14, 2026 · regulation last amended June 4, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) A holder of a licence, if they conduct antimicrobial treatment of cannabis at a location other than the site specified in the licence, must retain a document that contains the following information:
(a) a description of the cannabis, including, if applicable, the brand name;
(b) the date on which the cannabis leaves the site specified in the licence and the quantity that leaves the site;
(c) the name of the person that receives the cannabis at the location where the treatment is to be conducted;
(d) the address of the location referred to in paragraph (c);
(e) the name of the person from which the cannabis is received after the treatment;
(f) the address of the site to which the cannabis is returned, or of the location to which it is distributed, after the treatment; and
(g) the date on which the cannabis is received at the site or location referred to in paragraph (f) and the quantity that is received.
(2) The document must be retained for at least two years after the day on which it is prepared.
Read the Cannabis Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27; Controlled Drugs and Substances Act, S.C. 1996, c. 19; Cannabis Act, S.C. 2018, c. 16.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.